Heterogeneous photocatalysis is an advanced, efficient oxidation process that uses solar energy to be sustainable and low-cost compared to conventional wastewater treatments. This study synthesized BiOI/Fe₃O₄ using the solvothermal technique, evaluating stoichiometric ratios of Bi/Fe (2:1, 3:1, 5:1, and 7:1) under simulated solar irradiation to optimize the degradation of caffeic acid, a pollutant found in wastewater from the wine and pisco industry. The nanomaterial with a 5:1 ratio (BF-5) was the most effective, achieving a degradation of 77.2% in 180 min. Characterization by X-ray Diffraction (XRD), Transmission Electron Microscopy (TEM), Brunauer–Emmett–Teller (BET), Barrett–Joyner–Halenda (BJH), Fourier Transform Infrared Spectroscopy (FTIR), Diffuse Reflectance Spectroscopy (DRS), and Vibrating Sample Magnetometry (VSM) showed that BF-5 has a porous three-dimensional structure with BiOI nanosheets coating the Fe₃O₄ surface, while retaining the pristine BiOI properties. The magnetite provided magnetic properties that facilitated the recovery of the photocatalyst, reaching 89.4% recovery. These findings highlight the potential of BF-5 as an efficient and recoverable photocatalyst for industrial applications. The technical, economic, and environmental feasibility were also evaluated at the technological readiness level (TRL) to project solar photocatalysis in real applications.

Cancer and infectious diseases are two of the world’s major public health problems. Gemcitabine (GEM) is an effective chemotherapeutic agent against several types of cancer. In this study, we developed macrocapsules incorporating GEM into a chitosan matrix blended with magnetite and zeolite by ionic gelation. Physicochemical characterization was performed using HRTEM-ED, XRD, FESEM–EDS, FT-IR, TGA, encapsulation efficiency (%E.E.), and release profiles at pHs 7.4 and 5.0. Cell viability tests against A549 and H1299 cell lines, and microbiological properties against staphylococcal strains were performed. Our results revealed the successful production of hemispherical capsules with an average diameter of 1.22 mm, a rough surface, and characteristic FT-IR material interaction bands. The macrocapsules showed a high GEM encapsulation efficiency of over 86% and controlled release over 24 h. Cell viability assays revealed that similar cytotoxic effects to free GEM were achieved with a 45-fold lower GEM concentration, suggesting reduced dosing requirements and potentially fewer side effects. Additionally, the macrocapsules demonstrated potent antimicrobial activity, reducing Staphylococcus epidermidis growth by over 90%. These results highlight the macrocapsules dual role as a chemotherapeutic and antimicrobial agent, offering a promising strategy for treating lung cancer in patients at risk of infectious diseases or who are immunosuppressed.

The solid state thione-thiol equilibrium in 4,6-diphenyl-3,4-dihydropyrimidine-2(1H)-thione (C₁₆H₁₄N₂S) is analyzed through three different techniques, viz: Single Cristal X-Ray Diffraction (SCXRD), Nuclear Magnetic Resonance (NMR) and Fourier Transformed Infra-Red spectroscopy (FTIR), each one providing complementary information to the solution of the problem. The existence of thione-thiol equilibrium is firmly established, both in solution (by HNMR techniques) as in the solid state (by FTIR methods), and even if no traces of the thiol form could be found via SCXRD, some hints about the way in which the coexistence of both forms could be structurally achieved are provided by the structural analysis. In order to confirm the existence of this equilibrium, theoretical calculations were carried out at the B3LYP/6-311G(d,p) level theory, and a double proton transfer reaction is proposed.

Cancer and infectious diseases are two of the world's major public health problems. Gemcitabine (GEM) is an effective chemotherapeutic agent against several types of cancer. In this study, we developed macrocapsules by incorporating GEM into a chitosan matrix blended with magnetite and zeolite. The physico-chemical characterization of the precursor materials and the new delivery system was carried out by HRTEM-ED, XRD, FESEM-EDS, FT-IR, TGA, encapsulation efficiency (%E.E.) and release profiles at pH 7.4 and 5.0. Cell viability tests on A549 and H1299 cell lines and microbiological properties against staphylococcal strains were performed. Our results revealed the successful production of hemispherical capsules with an average diameter of 1.22 mm, a rough surface and characteristic FT-IR material interaction bands. GEM encapsulation rates exceeded 80%, and release profiles were well-controlled over 24 hours at tested pH levels. Notably, cell viability in H1299 cells was lower than the free GEM control. Moreover, the formulation exhibited potent antimicrobial activity against Staphylococcus epidermidis, highlighting its dual action as a chemotherapeutic and antimicrobial agent. This dual effect underscores the potential of these macrocapsules as innovative delivery system for treating lung cancer in patients who are also at risk of infectious diseases and who are immunosuppressed.